Wheeler-Jones C - Search Results

1

Endotoxin-induced activation of equine digital vein endothelial cells: role of p38 MAPK.

Brooks AC, Menzies-Gow NJ, Wheeler-Jones C, Bailey SR, Cunningham FM, Elliott J. Brooks AC, et al. Vet Immunol Immunopathol. 2009 Jun 15;129(3-4):174-80. doi: 10.1016/j.vetimm.2008.11.008. Epub 2008 Nov 7. Vet Immunol Immunopathol. 2009. PMID: 19108900

2

Agonist-specific cross talk between ERKs and p38(mapk) regulates PGI(2) synthesis in endothelium.

Houliston RA, Pearson JD, Wheeler-Jones CP. Houliston RA, et al. Am J Physiol Cell Physiol. 2001 Oct;281(4):C1266-76. doi: 10.1152/ajpcell.2001.281.4.C1266. Am J Physiol Cell Physiol. 2001. PMID: 11546664 Free article.

3

sPLA(2) cooperates with cPLA(2)alpha to regulate prostacyclin synthesis in human endothelial cells.

Houliston RA, Wheeler-Jones CP. Houliston RA, et al. Biochem Biophys Res Commun. 2001 Oct 5;287(4):881-7. doi: 10.1006/bbrc.2001.5681. Biochem Biophys Res Commun. 2001. PMID: 11573947

4

Uptake of 5-hydroxytryptamine by equine digital vein endothelial cells: inhibition by amines found in the equine caecum.

Bailey SR, Wheeler-Jones C, Elliott J. Bailey SR, et al. Equine Vet J. 2003 Mar;35(2):164-9. doi: 10.2746/042516403776114171. Equine Vet J. 2003. PMID: 12638793

5

Chylomicron-remnant-like particles modify production of vasoactive mediators by endothelial cells.

Evans M, Berhane Y, Botham KM, Elliott J, Wheeler-Jones CP. Evans M, et al. Biochem Soc Trans. 2004 Feb;32(Pt 1):110-2. doi: 10.1042/bst0320110. Biochem Soc Trans. 2004. PMID: 14748725

6

In-vitro contraction of the equine aortic valve.

Bowen IM, Marr CM, Chester AH, Wheeler-Jones CP, Elliott J. Bowen IM, et al. J Heart Valve Dis. 2004 Jul;13(4):593-9. J Heart Valve Dis. 2004. PMID: 15311865

7

Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development.

Botham KM, Bravo E, Elliott J, Wheeler-Jones CP. Botham KM, et al. Curr Pharm Des. 2005;11(28):3681-95. doi: 10.2174/138161205774580732. Curr Pharm Des. 2005. PMID: 16305504 Review.

8

A specific mechanomodulatory role for p38 MAPK in embryonic joint articular surface cell MEK-ERK pathway regulation.

Lewthwaite JC, Bastow ER, Lamb KJ, Blenis J, Wheeler-Jones CP, Pitsillides AA. Lewthwaite JC, et al. J Biol Chem. 2006 Apr 21;281(16):11011-8. doi: 10.1074/jbc.M510680200. Epub 2006 Feb 7. J Biol Chem. 2006. PMID: 16464862 Free article.

9

Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-kappaB pathways.

Syeda F, Grosjean J, Houliston RA, Keogh RJ, Carter TD, Paleolog E, Wheeler-Jones CP. Syeda F, et al. J Biol Chem. 2006 Apr 28;281(17):11792-804. doi: 10.1074/jbc.M509292200. Epub 2006 Feb 8. J Biol Chem. 2006. PMID: 16467309 Free article.

10

Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells.

Ritchie E, Saka M, Mackenzie C, Drummond R, Wheeler-Jones C, Kanke T, Plevin R. Ritchie E, et al. Br J Pharmacol. 2007 Apr;150(8):1044-54. doi: 10.1038/sj.bjp.0707150. Epub 2007 Mar 5. Br J Pharmacol. 2007. PMID: 17339845 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters